Philips is bringing its MicroDose Mammography system to North America. The device 
utilizes X-ray photon-counting detectors that deliver high image resolution at a lower radiation dose than traditional full field digital mammography systems.
According to two studies cited by Philips, an up to 50% dose reduction is possible using the MicroDose device.
MicroDose is the only FDA-cleared mammography system that uses X-ray photon-counting technology. Similar to light-emitting diode (LED) lighting which uses less wattage than traditional incandescent bulbs while providing high light output, the Philips MicroDose patented photon-counting detector utilizes less radiation while delivering excellent image quality. MicroDose is also designed to offer a less stressful mammography experience by providing curved support and a comfortably warm positioning surface. The ergonomic operation makes it easy for clinicians to focus on the patient. Furthermore, the exam – including image acquisition – takes less than five minutes, offering speed, convenience, improved throughput and productivity.
Additionally, the MicroDose photon-counting detector technology presents opportunities for future breast applications not typical of other FFDM systems, providing the option for continued advancements beyond 2D anatomical breast images in an easy and cost-effective way.
Press release: Philips Enters North American Mammography Market, Underscoring its Global Commitment to Women’s Health Care